Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $65 - $74
-1 Reduced -0.0%
35,189 $2.44 Million
Q4 2022

Feb 09, 2023

SELL
$68.48 - $81.09 $16,503 - $19,542
-241 Reduced 0.68%
35,190 $2.53 Million
Q3 2022

Nov 07, 2022

BUY
$0.13 - $76.84 $8 - $5,225
68 Added 0.19%
35,431 $2.52 Million
Q1 2022

Apr 28, 2022

SELL
$61.48 - $73.72 $25,514 - $30,593
-415 Reduced 1.16%
35,363 $2.58 Million
Q4 2021

Feb 10, 2022

BUY
$53.63 - $62.52 $201,541 - $234,950
3,758 Added 11.74%
35,778 $2.23 Million
Q3 2021

Nov 05, 2021

BUY
$59.17 - $69.31 $113,783 - $133,283
1,923 Added 6.39%
32,020 $1.9 Million
Q2 2021

Jul 27, 2021

BUY
$61.91 - $67.42 $12,382 - $13,484
200 Added 0.67%
30,097 $2.01 Million
Q1 2021

May 07, 2021

BUY
$59.34 - $66.74 $18,988 - $21,356
320 Added 1.08%
29,897 $1.9 Million
Q4 2020

Feb 05, 2021

BUY
$57.74 - $65.43 $255,326 - $289,331
4,422 Added 17.58%
29,577 $1.82 Million
Q3 2020

Nov 03, 2020

BUY
$57.43 - $63.64 $8,155 - $9,036
142 Added 0.57%
25,155 $1.52 Million
Q2 2020

Jul 29, 2020

BUY
$54.82 - $64.09 $3,289 - $3,845
60 Added 0.24%
25,013 $1.47 Million
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $156,182 - $226,969
3,366 Added 15.59%
24,953 $1.4 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $93,056 - $121,383
1,891 Added 9.6%
21,587 $1.39 Million
Q3 2019

Oct 31, 2019

BUY
$42.77 - $50.71 $169,925 - $201,470
3,973 Added 25.27%
19,696 $999,000
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $701,560 - $775,772
15,723 New
15,723 $713,000
Q4 2017

Jan 31, 2018

SELL
$59.94 - $65.35 $83,916 - $91,489
-1,400 Closed
0 $0
Q3 2017

Nov 08, 2017

BUY
$55.23 - $63.74 $77,322 - $89,236
1,400
1,400 $90,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Malaga Cove Capital, LLC Portfolio

Follow Malaga Cove Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Malaga Cove Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Malaga Cove Capital, LLC with notifications on news.